Adaptations of Brain Energy Metabolism to Hypoglycemia

脑能量代谢对低血糖的适应

• 批准号: 8535731
• 负责人: Raimund Ingo Herzog
• 金额: $ 15.43万
• 依托单位: YALE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-09-15 至 2015-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8535731
• 关键词: Acetates; Acute; Address; Animal Model; Animals; Award; Basic Science; Blood Glucose; Brain; Brain Injuries; Caprylates; Carbohydrates; Carbon; Chronic; Citric Acid Cycle; Clinical; Clinical Research; Cognition; Cognitive; Complications of Diabetes Mellitus; Data; Dependence; Deterioration; Development; Diabetes Mellitus; Diabetic Angiopathies; Diet; Dietary Intervention; Energy Metabolism; Enrollment; Exposure to; Failure; Fellowship; Fright; Funding; Glucose; Goals; Health; Health Sciences; Hormones; Human; Hyperglycemia; Hypoglycemia; Impaired cognition; In Vivo NMR Spectroscopy; Incidence; Infusion procedures; Injury; Insulin; Insulin-Dependent Diabetes Mellitus; Investigation; Ketone Bodies; Ketones; Label; Laboratories; Measures; Medium chain fatty acid; Metabolic; Metabolism; Methods; Mind; Mitochondria; NMR Spectroscopy; National Research Service Awards; Neurons; Neurosciences; Pathway interactions; Patients; Performance; Physicians; Physiological; Plasma; Pyruvate Dehydrogenase Complex; Recurrence; Risk; Route; Scanning; Scientist; Stimulus; Symptoms; Technology; Testing; Therapeutic Uses; Time; Tissues; Training; Translating; Ursidae Family; Work; animal data; base; blood glucose regulation; brain metabolism; career; cognitive function; diabetic; diabetic patient; diabetic rat; follow-up; human subject; hypoglycemia unawareness; improved; in vivo; macrovascular disease; metabolic abnormality assessment; neuroprotection; neurotransmitter metabolism; novel; novel therapeutic intervention; novel therapeutics; prevent; programs; pyruvate dehydrogenase; response; type I diabetic; uptake

DESCRIPTION (provided by applicant): Diabetic complications can be reduced by normalization of blood glucose levels via intensive insulin therapy. This treatment, while effective, bears the risk of an increased incidence of recurrent hypoglycemia. It blunts the central counterregulatory response to low blood glucose (counterregulatory failure) and thereby magnifies the risk of severe hypoglycemia and brain injury. The overall goal of this proposal is to understand the changes in brain metabolism that underlie these phenomena and identify possible therapies in order to prevent them. We will determine the impact of a medium chain fatty acid enriched diet on brain metabolism in tightly controlled T1DM subjects with hypoglycemia unawareness and an animal model thereof. We will further test the hypothesis that chronic provision of medium chain fatty acids can improve cognitive performance under hypoglycemia in human subjects. Data gathered from our animal studies revealed a specific change of neuronal energy metabolism under hypoglycemia following exposure to antecedent recurrent hypoglycemia that make is more difficult for neurons to utilize fuels like glucose or lactate. We also found that after recurrent hypoglycemia, lactate uptake into the brain was facilitated, but because it could subsequently not be utilized by mitochondria as effectively as under control conditions, it may not be an ideal fuel. This let us to look for different alternate substrates that follow the same route of uptake as lactate, but enter metabolism via a different pathway. One group of fuels that fulfill these criteria are ketone bodies and medium chain fatty acids. Applying state of the art technologies like in vivo NMR spectroscopy to our animal model of recurrent hypoglycemia will allows us address the hypothesis that they are better suited to support metabolism. We will use this animal model to determine how diabetes confounds the adaptations induced by recurrent hypoglycemia alone and then go on to translate our findings to a clinical study of cognition and metabolism in intensively treated T1DM patients. Our work is the first step towards developing candidate molecules into novel therapies that would protect the brain from hypoglycemia induced brain injury. The projects proposed here are building on preliminary studies that I have performed during my NRSA fellowship training and since then. They will give me the ideal opportunity to continue my training in NMR spectroscopy and its application to neuroscience and diabetes related complications. Most of my training thus far has been in the use of basic science methods and animal models. Wanting to become a well trained physician scientist however I realized that I still needed more training in human investigation. To that end I enrolled in a Master of Health Sciences program to receive further training in translational methods. Funding under this career award will allow me to continue these activities and give me the protected time from clinical duties that I will need to accomplish my career goal of establishing myself as an independently funded physician-scientist, eventually with my own laboratory and workgroup. PUBLIC HEALTH RELEVANCE: Understanding the changes of brain energy substrate transport and metabolism in intensively treated type 1 diabetic patients will provide the basis for the identification of novel therapeutic approaches that could protect the brain from hypoglycemia induced injury. This in turn could then sustain normal brain metabolism under hypoglycemia and would also allow for tighter glucose control with better protection from long-term diabetic related complications.

描述（由申请人提供）：通过强化胰岛素治疗使血糖水平正常化可减少糖尿病并发症。这种治疗虽然有效，但有增加复发性低血糖发生率的风险。它减弱了中枢对低血糖的反调节反应（反调节失败），从而放大了严重低血糖和脑损伤的风险。该提案的总体目标是了解这些现象背后的大脑代谢变化，并确定可能的治疗方法以预防它们。我们将确定富含中链脂肪酸的饮食对低血糖无意识的严格控制的T1DM受试者及其动物模型的脑代谢的影响。我们将进一步检验长期提供中链脂肪酸可以改善人类受试者在低血糖情况下的认知表现的假设。从我们的动物研究中收集的数据显示，在暴露于先前复发的低血糖后，低血糖下神经元能量代谢的特定变化使得神经元更难以利用葡萄糖或乳酸等燃料。我们还发现，在反复低血糖后，促进了乳酸摄取到大脑中，但由于它随后不能像在对照条件下那样有效地被线粒体利用，因此它可能不是理想的燃料。这让我们寻找不同的替代底物，它们遵循与乳酸相同的摄取途径，但通过不同的途径进入代谢。满足这些标准的一组燃料是酮体和中链脂肪酸。将最先进的技术如体内NMR光谱应用于我们的复发性低血糖动物模型将使我们能够解决它们更适合支持代谢的假设。我们将使用该动物模型来确定糖尿病如何混淆单独由复发性低血糖诱导的适应，然后继续将我们的发现转化为强化治疗的T1DM患者的认知和代谢的临床研究。我们的工作是将候选分子开发成新疗法的第一步，该疗法将保护大脑免受低血糖引起的脑损伤。这里提出的项目是建立在我在NRSA奖学金培训期间和此后进行的初步研究的基础上。他们将给我一个理想的机会，继续我在核磁共振光谱学及其应用于神经科学和糖尿病相关并发症的培训。到目前为止，我的大部分训练都是使用基础科学方法和动物模型。想要成为一名训练有素的医生科学家，然而，我意识到我仍然需要更多的人类调查培训。为此，我参加了健康科学硕士课程，接受进一步的翻译方法培训。在这个职业奖下的资金将使我能够继续这些活动，并给我从临床职责，我将需要完成我的职业目标，建立自己作为一个独立资助的医生，科学家，最终与我自己的实验室和实验室的保护时间。 公共卫生关系：了解强化治疗的1型糖尿病患者脑能量底物转运和代谢的变化，将为确定新的治疗方法提供基础，可以保护脑免受低血糖引起的损伤。这反过来又可以在低血糖的情况下维持正常的大脑代谢，并且还可以更严格地控制血糖，更好地防止长期糖尿病相关并发症。